Ultima-Tesamorelin 2mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE GHRH Peptide

Your security is our priority; that's why all products are shipped without branding.

Introducing Tesamorelin, an innovative medication designed with a growth hormone-releasing factor (GRF) to target excess abdominal fat. This treatment is specifically designed for individuals with HIV who are experiencing lipodystrophy, a condition often resulting from certain HIV therapies.

It's essential to understand that Tesamorelin is not intended for weight loss or obesity management; instead, it focuses on reducing excess abdominal fat in those affected by lipodystrophy.

**Important Considerations:**

• As the long-term cardiovascular safety and benefits of Tesamorelin remain unstudied, it?s vital to assess the continuation of treatment in patients who do not show significant improvements, as indicated by reductions in visceral fat through waist circumference or CT imaging.
• It is crucial to note that Tesamorelin is not approved for weight loss, as it maintains a weight-neutral effect.
• Current research does not support the notion that Tesamorelin enhances adherence to antiretroviral treatments for HIV-positive patients.

**General Dosage Guidelines:**

The recommended dosage is 2 mg of Tesamorelin administered subcutaneously once daily. For optimal results, inject into the abdomen, and remember to rotate your injection sites. Avoid areas with scar tissue, bruises, or proximity to the navel.

**Reconstitution Instructions:**

To prepare Tesamorelin, use the included diluent. Combine the 2 mg vial of Tesamorelin with 2.1 mL of the diluent. Gently roll the vial in your hands for 30 seconds to mix?do not shake. For detailed reconstitution steps, refer to the INSTRUCTIONS FOR USE leaflet that accompanies the Tesamorelin and diluent packaging.

Administer Tesamorelin immediately after reconstitution, discarding any unused solution. Never freeze or refrigerate the reconstituted product.

**Administration:**

Prior to administration, inspect the reconstituted Tesamorelin solution for clarity and color?only inject if it appears clear, colorless, and free from particulate matter. Inject subcutaneously into the abdominal skin, taking care to rotate sites and avoiding areas with scar tissue, bruises, or near the navel.